Brain pacemaker trial aims to tame severe childhood seizures
NCT ID NCT06924086
First seen Jan 03, 2026 · Last updated May 20, 2026 · Updated 26 times
Summary
This trial tests whether deep brain stimulation (DBS) can safely reduce seizure frequency in 22 children aged 5-14 with Lennox-Gastaut syndrome, a severe form of epilepsy. Participants receive an implanted device that sends electrical pulses to the brain. The study is double-blinded and randomized, meaning neither families nor doctors know who gets active stimulation initially. It aims to improve seizure control, not cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LENNOX-GASTAUT SYNDROME (LGS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Great Ormond Street Hospital NHS Foundation Trust
RECRUITINGLondon, United Kingdom
Contact
Contact
Conditions
Explore the condition pages connected to this study.